Retaglutide is a cutting-edge GLP-1 receptor agonist currently under investigation for the management of metabolic disorders. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally https://isaiahfsyw113503.blogdun.com/39680715/trelaglutide-exploring-a-new-therapy-for-chronic-diseases